AlphaCentric Advisors »

Sagimet Biosciences Inc-a shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 185k 5.42

More positions owned by AlphaCentric Advisors

Pfizer (PFE)
Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
United Therapeutics Corporation (UTHR)
Pacira Pharmaceuticals (PCRX)
BioCryst Pharmaceuticals (BCRX)
Galapagos Nv Spon Adr (GLPG)
Argenx Se Sponsored Adr (ARGX)
Two Harbors Inventment Corpo Note 6.250% 1/1
Inari Medical Ord (NARI)
Docgo (DCGO)
Beigene Sponsored Adr (BGNE)
Ellington Financial Inc ellington financ (EFC)
Axsome Therapeutics (AXSM)
MGIC Investment (MTG)

View all positions for AlphaCentric Advisors

Top funds holding Sagimet Biosciences Inc-a

NEA Management Company
Baker Bros. Advisors
Hillhouse Capital Advisors
Artal Group
Partner Fund Management
Alyeska Investment Group
Blue Owl Capital Holdings
Vanguard Group
Dumac
AlphaCentric Advisors
Federated Investors
Bank of New York Mellon
Victory Capital Management
Millennium Management
Two Sigma Investments

View all funds holding Sagimet Biosciences Inc-a